1. Wang, Shaobo, Qi, Yanhua, Zhao, Rongrong, Li, Gang, Xue, Hao. . Copy number gain of FAM131B-AS2 promotes the progression of glioblastoma by mitigating replication stress. In Neuro-oncology, 26, 1027-1041. doi:10.1093/neuonc/noae014. https://pubmed.ncbi.nlm.nih.gov/38285005/
2. Al-Eitan, Laith N, Al-Dalala, Islam M, Elshammari, Afrah K, Aljamal, Hanan A, Alghamdi, Mansour A. 2020. Genetic Association of Epilepsy and Anti-Epileptic Drugs Treatment in Jordanian Patients. In Pharmacogenomics and personalized medicine, 13, 503-510. doi:10.2147/PGPM.S273125. https://pubmed.ncbi.nlm.nih.gov/33116764/
3. Cin, Huriye, Meyer, Claus, Herr, Ricarda, Korshunov, Andrey, Pfister, Stefan M. 2011. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma. In Acta neuropathologica, 121, 763-74. doi:10.1007/s00401-011-0817-z. https://pubmed.ncbi.nlm.nih.gov/21424530/
4. Busse, Tracy M, Roth, Jacquelyn J, Wilmoth, Donna, Tooke, Laura, Biegel, Jaclyn A. 2017. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients. In Genes, chromosomes & cancer, 56, 730-749. doi:10.1002/gcc.22477. https://pubmed.ncbi.nlm.nih.gov/28597942/
智鼠故事 
